Evidence map›Paper›PMID 12488423›Full record

ArticleThe Journal of clinical investigation2002

A full complement of receptors in immune complex diseases.

Jeffrey V Ravetch

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  8. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. FcgammaRII and multi-system autoimmune disease.Springer seminars in immunopathology · 2006
    Review
  17. Article
  18. Article
  19. C5a and Fcgamma receptors: a mutual admiration society.The Journal of clinical investigation · 2006
    Article
  20. Human dendritic cell subsets for vaccination.Journal of clinical immunology · 2005
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Jeffrey V RavetchLaboratory of Molecular Genetics and Immunology, Rockefeller University, New York, New York 10021, USA. ravetch@rockefeller.edu
Rockefeller University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsArthus ReactionComplement C5aHumansImmune Complex DiseasesImmunoglobulin GInflammationMiceMice, KnockoutModels, ImmunologicalReceptors, FcSignal TransductionComplement C5aImmunoglobulin GReceptors, Fc

Identifiers

PMID12488423
PMCPMC151658
OpenAlexW2046621895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.